He Y - Search Results

1

Identification and Analysis of Potential Immune-Related Biomarkers in Endometriosis.

He Y, Li J, Qu Y, Sun L, Zhao X, Wu H, Zhang G. He Y, et al. J Immunol Res. 2023 Jan 10;2023:2975581. doi: 10.1155/2023/2975581. eCollection 2023. J Immunol Res. 2023. PMID: 36660246 Free PMC article.

2

Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression.

Guo Q, Cheng Y, Liang T, He Y, Ren C, Sun L, Zhang G. Guo Q, et al. Among authors: he y. Sci Rep. 2015 Dec 3;5:17683. doi: 10.1038/srep17683. Sci Rep. 2015. PMID: 26631459 Free PMC article.

3

Characteristics of Human Endometrium-Derived Mesenchymal Stem Cells and Their Tropism to Endometriosis.

Cheng Y, Li L, Wang D, Guo Q, He Y, Liang T, Sun L, Wang X, Cheng Y, Zhang G. Cheng Y, et al. Among authors: he y. Stem Cells Int. 2017;2017:4794827. doi: 10.1155/2017/4794827. Epub 2017 Jul 6. Stem Cells Int. 2017. PMID: 28761446 Free PMC article.

4

Constructing an ovarian cancer metastasis index by dissecting medical records.

Qu Y, He Y, Li Z, Chen X, Liu Q, Zou S, Kong C, Liu Y, Gao C, Zhang G, Zhu W. Qu Y, et al. Among authors: he y. Oncotarget. 2017 Nov 6;8(60):102212-102222. doi: 10.18632/oncotarget.22336. eCollection 2017 Nov 24. Oncotarget. 2017. PMID: 29254237 Free PMC article.

5

Abnormal activation of the sonic hedgehog signaling pathway in endometriosis and its diagnostic potency.

He Y, Guo Q, Cheng Y, Qu Y, Sun L, Kong C, Lei L, Zhang G. He Y, et al. Fertil Steril. 2018 Jul 1;110(1):128-136.e2. doi: 10.1016/j.fertnstert.2018.02.138. Fertil Steril. 2018. PMID: 29980254 Free article.

6

Identification of potential prognostic TF-associated lncRNAs for predicting survival in ovarian cancer.

Guo Q, He Y, Sun L, Kong C, Cheng Y, Wang P, Zhang G. Guo Q, et al. Among authors: he y. J Cell Mol Med. 2019 Mar;23(3):1840-1851. doi: 10.1111/jcmm.14084. Epub 2018 Dec 13. J Cell Mol Med. 2019. PMID: 30549251 Free PMC article.

7

In silico detection of potential prognostic circRNAs through a re-annotation strategy in ovarian cancer.

Guo Q, He Y, Sun L, Kong C, Cheng Y, Zhang G. Guo Q, et al. Among authors: he y. Oncol Lett. 2019 Apr;17(4):3677-3686. doi: 10.3892/ol.2019.10021. Epub 2019 Feb 6. Oncol Lett. 2019. PMID: 30930980 Free PMC article.

8

Livin promotes tumor progression through YAP activation in ovarian cancer.

Gao J, Han W, He Y, Zhou J, Miao J, Zhang G. Gao J, et al. Among authors: he y. Am J Cancer Res. 2020 Oct 1;10(10):3179-3193. eCollection 2020. Am J Cancer Res. 2020. PMID: 33163264 Free PMC article.

9

Immune Characterization of Ovarian Cancer Reveals New Cell Subtypes With Different Prognoses, Immune Risks, and Molecular Mechanisms.

Cong S, Guo Q, Cheng Y, He Y, Zhao X, Kong C, Ning S, Zhang G. Cong S, et al. Among authors: he y. Front Cell Dev Biol. 2020 Dec 21;8:614139. doi: 10.3389/fcell.2020.614139. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33409283 Free PMC article.

10

LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer.

Jiang X, Cheng Y, He Y, Cong S, Sun L, Wu D, Wu H, Zhang G. Jiang X, et al. Among authors: he y. Cancer Manag Res. 2021 May 11;13:3817-3826. doi: 10.2147/CMAR.S295097. eCollection 2021. Cancer Manag Res. 2021. PMID: 34007214 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,850 results

Search Page

Filters